Condition
Valve Replacement Surgery
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07431762Phase 4RecruitingPrimary
Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprosthetic Heart Valve Replacement
NCT07434661Phase 3Not Yet Recruiting
Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR
NCT07205393Not ApplicableRecruitingPrimary
Phase One Cardiac Rehabilitation Outcomes Post Valve Replacement Surgery
Showing all 3 trials